Multi-omics analyses prioritize potential biomarkers and drug targets for obstructive sleep apnea.
STUDY OBJECTIVES Obstructive sleep apnea (OSA) remains a prevalent sleep disorder with incompletely characterized molecular mechanisms and evolving pharmacological options. We aimed to identify molecular biomarkers associated with OSA and prioritize candidates for further evaluation. METHODS OSA genome-wide associati...